The ADVANCED prostate cancer needs survey

A researcher at the Medical University of South Carolina (MUSC) College of Nursing is conducting a study to better understand supportive care needs and quality of life among individuals with ADVANCED forms of prostate cancer and is seeking just a few more participants to complete this survey. Can you help (if you haven’t already)? … READ MORE …

Do you have ADVANCED prostate cancer?

A researcher at the Medical University of South Carolina (MUSC) College of Nursing is conducting a study to better understand supportive care needs and quality of life among individuals with ADVANCED forms of prostate cancer. If you live in the USA or its territories and are a patient with ADVANCED (i.e., recurrent, non-localized, or metastatic) prostate cancer, you are potentially eligible to participate. … READ MORE …

New guidelines for management of advanced prostate cancer

The American Urological Association (AUA), together with the American Society for Radiation Oncology (ASTRO) and the Society for Urologic Oncology (SUO), has just issued a new set of guidelines for the management of advanced prostate cancer (see here). … READ MORE …

Areas of consensus at APCCC last year … see Table 1

So your sitemaster has been looking through the full report from the APCCC meeting held in Basel last year — as he promised he would. … READ MORE …

Detailed data from the APCCC meeting in Basel now available

Last August your sitemaster attended and reported from the third iteration of the Advanced Prostate Cancer Consensus Conference (APCCC), held in Basel, Switzerland (see here, here, and here). … READ MORE …

The APCCC in Basel, Switzerland: where to get the details

Our friends at UroToday are now making available the individual presenters’ slides and other materials from the 3rd Advanced Prostate Cancer Consensus Conference (APCCC) that ended in Basel, Switzerland, last Saturday, as well as detailed interviews on specific topics that were recorded at the meeting. … READ MORE …

The APCCC in Basel, Switzerland: Day 3

So today, the third day of the meeting, was “voting day” on a total of 123 questions carefully crafted by the organizers prior to the meeting. The questions had all gone through three cycles of review and revision prior to the meeting. … READ MORE …

The APCCC in Basel, Switzerland: Day 2

The second day of the APCCC here in Basel ran for 10 hours and encompassed a total of six sessions, as follows: … READ MORE …

Adjuvant chemotherapy does NOT improve BDFS rates in men with intermediate- and high-risk prostate cancer

With the third Advanced Prostate Cancer Consensus Conference (APCCC) due to start here in Basel, Switzerland, this morning, there is an important new set of data that will help to inform some of the discussions. … READ MORE …

Geographic risk for advanced and metastatic prostate cancer

New research data on the epidemiology of advanced prostate cancer here in the US has confirmed something that has long been understood (albeit not previously as well documented). … READ MORE …

The upcoming APCCC 2019 meeting on advanced prostate cancer

The first iteration of the Advanced Prostate Cancer Consensus Conference (APCCC) was held in St. Gallen, Switzerland, in 2017, and the second iteration is upcoming in late August this year — this time in Basel. … READ MORE …

Vigorous exercise and prostate cancer risk

A new study just published in European Urology appears to have confirmed a connection between regular, vigorous exercise (in men of 45 to 75 years of age) and a reduced risk for aggressive (i.e., advanced and lethal) forms of prostate cancer. … READ MORE …

A rare case of cutaneous, metastatic prostate cancer

Last week we learned of a distinctly unusual case of advanced prostate cancer, and the patient has given us his permission to provide our readers with some specific information about his case. … READ MORE …

Metformin + ADT in treatment of advanced prostate cancer

Yet another study, just published in the Journal of Urology, has indicated a clear association between the use of metformin along with androgen deprivation therapy (ADT) in the treatment of advanced forms of prostate cancer. … READ MORE …

Two leading women talk about the future of treatment of advanced prostate cancer

Nearly 30 years ago, when your sitemaster first attended a prostate cancer meeting (in 1989) related to the upcoming approval of a new drug called flutamide, he doesn’t remember there being a single clinician at the meeting who was female — out of the 150 or so urologists and medical oncologists who had been invited. … READ MORE …